Pfizer to close Durham and Morrisville, North Carolina facilities amid major restructuring effort

In a strategic initiative to streamline operations, Pfizer said it would close facilities in Durham and Morrisville, North Carolina. The company aims to cut at least $3.5 billion in costs. 

The company now employs more than 80,000 people worldwide, with roughly 4,000 based in North Carolina.

The closures will not affect Pfizer’s two largest facilities in North Carolina — Sanford and Rocky Mount. The Rocky Mount facility, which specializes in producing injectable medicines for hospitals, employs approximately 3,200 people and has recently resumed operations after a tornado damaged it in July. The Durham Clinical Manufacturing Facility, on the other hand, opened in December 2021. The company initially planned for the facility to create 50 jobs and relocate 40 employees from Chapel Hill. The exact number of people employed at the facility at the time of the announcement remains unclear.

The company has lowered its full-year revenue guidance to $58.0 to $61.…

Read more
  • 0

Why Wake County, North Carolina is gaining ground as a biotech hub

A rendering of the future Amgen facility in Holly Springs, North Carolina. Image courtesy of Amgen.

Holly Springs and the surrounding Wake County in North Carolina area are actively working to recruit life sciences companies.

Those efforts are proving successful.

Amgen (Nasdaq:AMGN) recently broke ground on a $550 million biomanufacturing plant in Holly Springs, a town of about 41,000 in the county. The company anticipates that the facility will be operational in 2025.

In October, Fujifilm Diosynth announced plans to build a $1.5 billion facility in Holly Springs as well. The plant could eventually employ more than 700 people. The company also anticipates the plant will be operational in 2025. It will focus on drug substance manufacturing.

Holly Springs is based near the Research Triangle Park and Raleigh-Durham International Airport.

Amgen’s decision to build a plant in Holly Spr…

Read more
  • 0

Lilly to invest $1B in new plant in North Carolina

Eli Lilly and Co. (NYSE:LLY) said it would invest more than $1 billion to build a new manufacturing facility in Concord, North Carolina.

The company says it would hire almost 600 new employees to staff the new site, which will include a campus of five buildings focused on manufacturing parenteral (injectable) products and devices.

The average salary for the new employees will be approximately $70,000.

The location of the proposed 800,000-ft2 site was formerly occupied by a Philip Morris plant.

“Expanding our manufacturing footprint in North Carolina enables us to continue to produce today’s medicines while providing additional capacity to manufacture the medicines of tomorrow,” said Edgardo Hernandez, senior vice president and president, Lilly Manufacturing Operations, in a statement. “We are pleased to again partner with North Carolina to bring jobs to American workers and provide more medicines that patients need to addre…

Read more
  • 0